NOS-2 signaling and cancer therapy

IUBMB Life

Volumn 64, Issue 8, 2012, Pages 676-683

  Bian, Ka ^a   Ghassemi, Farshid ^a   Sotolongo, Alex ^a   Siu, Alan ^a   Shauger, Lauren ^a   Kots, Alex ^a   Murad, Ferid ^a  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

drug discovery; human molecular disease; nitric oxide; nitrosative stress; signaling

Indexed keywords

CD163 ANTIGEN; CD31 ANTIGEN; CD68 ANTIGEN; CD8 ANTIGEN; CYCLIC GMP; DNA VACCINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GAMMA INTERFERON; GELATINASE B; GUANYLATE CYCLASE; HLA DR ANTIGEN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 4; ISOBUTYLMETHYLXANTHINE; N [3 (AMINOMETHYL)BENZYL]ACETAMIDINE; N6 (1 IMINOETHYL)LYSINE; N6 (1 IMINOETHYL)LYSINE 5 TETRAZOLE AMIDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; REACTIVE NITROGEN SPECIES; SC 51; TRANSCRIPTION FACTOR RELA; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASCULOTROPIN; ZAPRINAST;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; B LYMPHOCYTE; BLOOD VESSEL; CANCER CELL CULTURE; CANCER THERAPY; CELL TYPE; COLON CARCINOMA; CONNECTIVE TISSUE; ENZYME INHIBITION; HUMAN; INFLAMMATION; INFLAMMATORY CELL; INNATE IMMUNITY; KAPOSI SARCOMA; LIVER CELL CARCINOMA; MALIGNANT NEOPLASTIC DISEASE; MELANOMA; NATURAL KILLER CELL; NEUROTRANSMISSION; NONHUMAN; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; SOLID TUMOR; STOMACH CARCINOMA; STROMA; T LYMPHOCYTE SUBPOPULATION; TREATMENT OUTCOME; TUMOR ASSOCIATED LEUKOCYTE; TUMOR GROWTH; TUMOR IMMUNITY; TUMOR MICROENVIRONMENT; VASODILATATION;

ANIMALS; CELL LINE, TUMOR; CYCLIC GMP; GUANYLATE CYCLASE; HUMANS; MACROPHAGES; MICE; NEOPLASMS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT;

EID: 84864243363     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1002/iub.1057     Document Type: Review

References (90)

1. Bian, K., and, Murad, F., (2003) Nitric oxide (NO) - biogeneration, regulation, and relevance to human diseases. Front Biosci. 8, d264-d278. (Pubitemid 39069977)
2. Bian, K., Doursout, M. F., and, Murad, F., (2008) Vascular system: role of nitric oxide in cardiovascular diseases. J. Clin. Hypertens. (Greenwich) 10, 304-310.
3. Muntane, J., and, la Mata, M. D., (2010) Nitric oxide and cancer. World J. Hepatol. 2, 337-344.
4. Lee, N. C., Bouvet, M., Nardin, S., Jiang, P., Baranov, E., Rashidi, B., Yang, M., Wang, X., Moossa, A. R., and, Hoffma, R. M., (2000) Antimetastatic efficacy of adjuvant gemcitabine in a pancreatic cancer orthotopic model. Clin. Exp. Metastasis 18, 379-384. (Pubitemid 32588617)
5. Natarajan, R., Gupta, S., Fisher, B. J., Ghosh, S., and, Fowler, A. A., III, (2001) Nitric oxide suppresses IL-8 transcription by inhibiting c-Jun N-terminal kinase-induced AP-1 activation. Exp. Cell Res. 266, 203-212. (Pubitemid 32579225)
6. Zhou, J., Fandrey, J., Schumann, J., Tiegs, G., and, Brune, B., (2003) NO and TNF-alpha released from activated macrophages stabilize HIF-1alpha in resting tubular LLC-PK1 cells. Am. J. Physiol. Cell Physiol. 284, C439-C446. (Pubitemid 36120082)
7. Schonhoff, C. M., Daou, M. C., Jones, S. N., Schiffer, C. A., and, Ross, A. H., (2002) Nitric oxide-mediated inhibition of Hdm2-p53 binding. Biochemistry 41, 13570-13574. (Pubitemid 35332692)
8. Li, C. Q., Kim, M. Y., Godoy, L. C., Thiantanawat, A., Trudel, L. J., and, Wogan, G. N., (2009) Nitric oxide activation of Keap1/Nrf2 signaling in human colon carcinoma cells. Proc. Natl. Acad. Sci. USA 106, 14547-14551.
9. Gonzalez, D., Drapier, J. C., and, Bouton, C., (2004) Endogenous nitration of iron regulatory protein-1 (IRP-1) in nitric oxide-producing murine macrophages: further insight into the mechanism of nitration in vivo and its impact on IRP-1 functions. J. Biol. Chem. 279, 43345-43351. (Pubitemid 39372229)
10. Kimura, H., and, Murad, F., (1975) Increased particulate and decreased soluble guanylate cyclase activity in regenerating liver, fetal liver, and hepatoma. Proc. Natl. Acad. Sci. USA 72, 1965-1969.
11. Criss, W. E., and, Murad, F., (1976) Urinary excretion of cyclic guanosine 3':5'-monophosphate and cyclic adenosine 3':5'-monophosphate in rats bearing transplantable liver and kidney tumors. Cancer Res. 36, 1714-1716.
12. Rao, C. V., (2004) Nitric oxide signaling in colon cancer chemoprevention. Mutat. Res. 555, 107-119. (Pubitemid 39345400)
13. Mujoo, K., Sharin, V. G., Martin, E., Choi, B. K., Sloan, C., Nikonoff, L. E., Kots, A. Y., and, Murad, F., (2010) Role of soluble guanylyl cyclase-cyclic GMP signaling in tumor cell proliferation. Nitric Oxide 22, 43-50.
14. Bredt, D. S., Hwang, P. M., Glatt, C. E., Lowenstein, C., Reed, R. R., and, Snyder, S. H., (1991) Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature 351, 714-718. (Pubitemid 21896670)
15. Schmidt, H. H., and, Murad, F., (1991) Purification and characterization of a human NO synthase. Biochem. Biophys. Res. Commun. 181, 1372-1377.
16. Nathan, C., and, Xie, Q. W., (1994) Nitric oxide synthases: roles, tolls, and controls. Cell 78, 915-918. (Pubitemid 24292319)
17. Janssens, S. P., Simouchi, A., Quertermous, T., Bloch, D. B., and, Bloch, K. D., (1992) Cloning and expression of a cDNA encoding human endothelium-derived relating factor/nitric oxide synthase. J. Biol. Chem. 267, 22694.
18. Pollock, J. S., Forstermann, U., Mitchell, J. A., Warner, T. D., Schmidt, H. H., Nakane, M.,. and, Murad, F., (1991) Purification and characterization of particulate endothelium-derived relaxing factor synthase from cultured and native bovine aortic endothelial cells. Proc. Natl. Acad. Sci. USA 88, 10480-10484. (Pubitemid 21915859)
19. Xie, Q. W., Whisnant, R., and, Nathan, C., (1993) Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon gamma and bacterial lipopolysaccharide. J. Exp. Med. 177, 1779-1784. (Pubitemid 23146145)
20. Bian, K., and, Murad, F., (2001) Diversity of endotoxin-induced nitrotyrosine formation in macrophage-endothelium-rich organs. Free Radic. Biol. Med. 31, 421-429. (Pubitemid 32728429)
21. Bian, K., Harari, Y., Zhong, M., Lai, M., Castro, G., Weisbrodt, N., and, Murad, F., (2001) Down-regulation of inducible nitric-oxide synthase (NOS-2) during parasite-induced gut inflammation: a path to identify a selective NOS-2 inhibitor. Mol. Pharmacol. 59, 939-947. (Pubitemid 32274023)
22. Kondo, S., Toyokuni, S., Tsuruyama, T., Ozeki, M., Tachibana, T., Echizenya, M., Hiai, H., Onodera, H., and, Imamura, M., (2002) Peroxynitrite-mediated stress is associated with proliferation of human metastatic colorectal carcinoma in the liver. Cancer Lett. 179, 87-93. (Pubitemid 34195657)
23. Kagoura, M., Matsui, C., Toyoda, M., and, Morohashi, M., (2001) Immunohistochemical study of inducible nitric oxide synthase in skin cancers. J. Cutan Pathol. 28, 476-481. (Pubitemid 32881885)
24. Calatayud, S., Barrachina, D., and, Esplugues, J. V., (2001) Nitric oxide: relation to integrity, injury, and healing of the gastric mucosa. Microsc. Res. Tech. 53, 325-335. (Pubitemid 32494582)
25. Abramson, S. B., Amin, A. R., Clancy, R. M., and, Attur, M., (2001) The role of nitric oxide in tissue destruction. Best Pract. Res. Clin. Rheumatol 15, 831-845. (Pubitemid 34092515)
26. Dawson, V. L., and, Dawson, T. M., (1998) Nitric oxide in neurodegeneration. Prog. Brain Res. 118, 215-229. (Pubitemid 28530669)
27. Heneka, M. T., and, Feinstein, D. L., (2001) Expression and function of inducible nitric oxide synthase in neurons. J. Neuroimmunol. 114, 8-18. (Pubitemid 32184720)
28. Amin, A. R., Attur, M., and, Abramson, S. B., (1999) Nitric oxide synthase and cyclooxygenases: distribution, regulation, and intervention in arthritis. Curr. Opin. Rheumatol. 11, 202-209. (Pubitemid 29257638)
29. Liu, J. S., Zhao, M. L., Brosnan, C. F., and, Lee, S. C., (2001) Expression of inducible nitric oxide synthase and nitrotyrosine in multiple sclerosis lesions. Am. J. Pathol. 158, 2057-2066. (Pubitemid 32545191)
30. Wilson, K. T., (2002) Angiogenic markers, neovascularization and malignant deformation of Barrett's esophagus. Dis. Esophagus 15, 16-21. (Pubitemid 34811994)
31. Franchi, A., Gallo, O., Paglierani, M., Sardi, I., Magnelli, L., Masini, E., and, Santucci, M., (2002) Inducible nitric oxide synthase expression in laryngeal neoplasia: correlation with angiogenesis. Head Neck 24, 16-23. (Pubitemid 34013850)
32. Morris, B. J., Markus, A., Glenn, C. L., Adams, D. J., Colagiuri, S., and, Wang, L., (2002) Association of a functional inducible nitric oxide synthase promoter variant with complications in type 2 diabetes. J. Mol. Med. 80, 96-104. (Pubitemid 34169817)
33. Johannesen, J., Pie, A., Pociot, F., Kristiansen, O. P., Karlsen, A. E., and, Nerup, J., (2001) Linkage of the human inducible nitric oxide synthase gene to type 1 diabetes. J. Clin. Endocrinol. Metab. 86, 2792-2796. (Pubitemid 32545741)
34. Xie, Q. W., Cho, H. J., Calaycay, J., Mumford, R. A., Swiderek, K. M., Lee, T. D., Ding, A., Troso, T., and, Nathan, C., (1992) Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 256, 225-228.
35. Xia, Y., and, Zweier, J. L., (1997) Superoxide and peroxynitrite generation from inducible nitric oxide synthase in macrophages. Proc. Natl. Acad. Sci. USA 94, 6954-6958. (Pubitemid 27281972)
36. Kaparakis, M., Walduck, A. K., Price, J. D., Pedersen, J. S., van Rooijen, N., Pearse, M. J., Wijburg, O. L., and, Strugnell, R. A., (2008) Macrophages are mediators of gastritis in acute Helicobacter pylori infection in C57BL/6 mice. Infect. Immun. 76, 2235-2239. (Pubitemid 351656160)
37. Grip, O., Janciauskiene, S., and, Lindgren, S., (2003) Macrophages in inflammatory bowel disease. Curr. Drug Targets Inflamm. Allergy 2, 155-160.
38. Heymann, F., Trautwein, C., and, Tacke, F., (2009) Monocytes and macrophages as cellular targets in liver fibrosis. Inflam. Allergy Drug Targets 8, 307-318.
39. Pollard, J. W., (2004) Tumour-educated macrophages promote tumour progression and metastasis. Nat. Rev. Cancer 4, 71-78. (Pubitemid 38082155)
40. Liu, G., Ma, H., Qiu, L., Li, L., Cao, Y., Ma, J., and, Zhao, Y., (2011) Phenotypic and functional switch of macrophages induced by regulatory CD4+CD25+ T cells in mice. Immunol. Cell Biol. 89, 130-142.
41. Martinez, F. O., Helming, L., and, Gordon, S., (2009) Alternative activation of macrophages: an immunologic functional perspective. Annu. Rev. Immunol. 27, 451-483.
42. Morris, S. M., Jr., Kepka-Lenhart, D., and, Chen, L. C., (1998) Differential regulation of arginases and inducible nitric oxide synthase in murine macrophage cells. Am. J. Physiol. 275, E740-E747.
43. Gordon, S., (2003) Alternative activation of macrophages. Nat. Rev. Immunol. 3, 23-35. (Pubitemid 37328697)
44. Balkwill, F., and, Mantovani, A., (2001) Inflammation and cancer: back to Virchow? Lancet 357, 539-545. (Pubitemid 32173595)
45. Bingle, L., Brown, N. J., and, Lewis, C. E., (2002) The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies. J. Pathol. 196, 254-265. (Pubitemid 34189413)
46. Ma, J., Liu, L., Che, G., Yu, N., Dai, F., and, You, Z., (2010) The M1 form of tumor-associated macrophages in non-small cell lung cancer is positively associated with survival time. BMC Cancer 10, 112.
47. Sinha, P., Clements, V. K., and, Ostrand-Rosenberg, S., (2005) Reduction of myeloid-derived suppressor cells and induction of M1 macrophages facilitate the rejection of established metastatic disease. J. Immunol. 174, 636-645. (Pubitemid 40094255)
48. Sica, A., Saccani, A., Bottazzi, B., Polentarutti, N., Vecchi, A., van Damme, J., and, Mantovani, A., (2000) Autocrine production of IL-10 mediates defective IL-12 production and NF-kappa B activation in tumor-associated macrophages. J. Immunol. 164, 762-767. (Pubitemid 30043699)
49. Guiducci, C., Vicari, A. P., Sangaletti, S., Trinchieri, G., and, Colombo, M. P., (2005) Redirecting in vivo elicited tumor infiltrating macrophages and dendritic cells towards tumor rejection. Cancer Res. 65, 3437-3446. (Pubitemid 40524630)
50. Rauh, M. J., Sly, L. M., Kalesnikoff, J., Hughes, M. R., Cao, L. P., Lam, V., and, Krystal, G., (2004) The role of SHIP1 in macrophage programming and activation. Biochem. Soc. Trans. 32, 785-788. (Pubitemid 39524379)
51. Luo, Y., Zhou, H., Krueger, J., Kaplan, C., Lee, S. H., Dolman, C., Markowitz, D., Wu, W., Liu, C., Reisfeld, R. A., and, Xiang, R., (2006) Targeting tumor-associated macrophages as a novel strategy against breast cancer. J. Clin. Invest. 116, 2132-2141. (Pubitemid 44162322)
52. Zhu, H., Li, J. T., Zheng, F., Martin, E., Kots, A. Y., Krumenacker, J. S., Choi, B. K., McCutcheon, I. E., Weisbrodt, N., Bogler, O., Murad, F., and, Bian, K., (2011) Restoring soluble guanylyl cyclase expression and function blocks the aggressive course of glioma. Mol. Pharmacol. 80, 1076-1084.
53. Fukumura, D., Kashiwagi, S., and, Jain, R. K., (2006) The role of nitric oxide in tumour progression. Nat. Rev. Cancer 6, 521-534. (Pubitemid 43980541)
54. Cobbs, C. S., Brenman, J. E., Aldape, K. D., Bredt, D. S., and, Israel, M. A., (1995) Expression of nitric oxide synthase in human central nervous system tumors. Cancer Res. 55, 727-730.
55. Ludwig, H. C., Feiz-Erfan, I., Bockermann, V., Behnke-Mursch, J., Schallock, K., and, Markakis, E., (2000) Expression of nitric oxide synthase isozymes (NOS I-III) by immunohistochemistry and DNA in situ hybridization. Correlation with macrophage presence, vascular endothelial growth factor (VEGF) and oedema volumetric data in 220 glioblastomas. Anticancer Res. 20, 299-304. (Pubitemid 30189770)
56. Broholm, H., Braendstrup, O., and, Lauritzen, M., (2001) Nitric oxide synthase expression of oligodendrogliomas. Clin. Neuropathol. 20, 233-238. (Pubitemid 33081705)
57. Broholm, H., Rubin, I., Kruse, A., Braendstrup, O., Schmidt, K., Skriver, E. B., and, Lauritzen, M., (2003) Nitric oxide synthase expression and enzymatic activity in human brain tumors. Clin. Neuropathol. 22, 273-281. (Pubitemid 37541366)
58. Bakshi, A., Nag, T. C., Wadhwa, S., Mahapatra, A. K., and, Sarkar, C., (1998) The expression of nitric oxide synthases in human brain tumours and peritumoral areas. J. Neurol. Sci. 155, 196-203. (Pubitemid 28139021)
59. Weninger, W., Rendl, M., Pammer, J., Mildner, M., Tschugguel, W., Schneeberger, C., Sturzl, M., and, Tschachler, E., (1998) Nitric oxide synthases in Kaposi's sarcoma are expressed predominantly by vessels and tissue macrophages. Lab Invest. 78, 949-955. (Pubitemid 28378209)
60. Murad, F., (1999) Discovery of some of the biological effects of nitric oxide and its role in cell signaling. Biosci. Rep. 19, 133-154. (Pubitemid 29455841)
61. Davis, K. L., Martin, E., Turko, I. V., and, Murad, F., (2001) Novel effects of nitric oxide. Annu. Rev. Pharmacol. Toxicol. 41, 203-236. (Pubitemid 32385888)
62. Hanafy, K. A., Krumenacker, J. S., and, Murad, F., (2001) NO, nitrotyrosine, and cyclic GMP in signal transduction. Med. Sci. Monit. 7, 801-819. (Pubitemid 32691766)
63. Ekmekcioglu, S., Ellerhorst, J., Smid, C. M., Prieto, V. G., Munsell, M., Buzaid, A. C., and, Grimm, E. A., (2000) Inducible nitric oxide synthase and nitrotyrosine in human metastatic melanoma tumors correlate with poor survival. Clin. Cancer Res. 6, 4768-4775. (Pubitemid 32110418)
64. MacMillan-Crow, L. A., Greendorfer, J. S., Vickers, S. M., and, Thompson, J. A., (2000) Tyrosine nitration of c-SRC tyrosine kinase in human pancreatic ductal adenocarcinoma. Arch. Biochem. Biophys. 377, 350-356. (Pubitemid 30331897)
65. Kato, H., Miyazaki, T., Yoshikawa, M., Nakajima, M., Fukai, Y., Tajima, K., Masuda, N., Tsutsumi, S., Tsukada, K., Nakajima, T., and, Kuwano, H., (2000) Nitrotyrosine in esophageal squamous cell carcinoma and relevance to p53 expression. Cancer Lett. 153, 121-127. (Pubitemid 30209853)
66. Gochman, E., Mahajna, J., Shenzer, P., Dahan, A., Blatt, A., Elyakim, R., and, Reznick, A. Z., (2012) The expression of iNOS and nitrotyrosine in colitis and colon cancer in humans. Acta Histochem.
67. Soini, Y., Haapasaari, K. M., Vaarala, M. H., Turpeenniemi-Hujanen, T., Karja, V., and, Karihtala, P., (2011) 8-hydroxydeguanosine and nitrotyrosine are prognostic factors in urinary bladder carcinoma. Int. J. Clin. Exp. Pathol. 4, 267-275.
68. Bian, K., Gao, Z., Weisbrodt, N., and, Murad, F., (2003) The nature of heme/iron-induced protein tyrosine nitration. Proc. Natl. Acad. Sci. USA 100, 5712-5717. (Pubitemid 36576873)
69. Eiserich, J. P., Hristova, M., Cross, C. E., Jones, A. D., Freeman, B. A., Halliwell, B., and, van der Vliet, A., (1998) Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature 391, 393-397. (Pubitemid 28093514)
70. Wu, W., Chen, Y., and, Hazen, S. L., (1999) Eosinophil peroxidase nitrates protein tyrosyl residues. Implications for oxidative damage by nitrating intermediates in eosinophilic inflammatory disorders. J. Biol. Chem. 274, 25933-25944.
71. Ahn, B., and, Ohshima, H., (2001) Suppression of intestinal polyposis in Apc(Min/+) mice by inhibiting nitric oxide production. Cancer Res. 61, 8357-8360. (Pubitemid 33131104)
72. Nam, K. T., Oh, S. Y., Ahn, B., Kim, Y. B., Jang, D. D., Yang, K. H., Hahm, K. B., and, Kim, D. Y., (2004) Decreased Helicobacter pylori associated gastric carcinogenesis in mice lacking inducible nitric oxide synthase. Gut 53, 1250-1255. (Pubitemid 39120106)
73. Kisley, L. R., Barrett, B. S., Bauer, A. K., Dwyer-Nield, L. D., Barthel, B., Meyer, A. M., Thompson, D. C., and, Malkinson, A. M., (2002) Genetic ablation of inducible nitric oxide synthase decreases mouse lung tumorigenesis. Cancer Res. 62, 6850-6856. (Pubitemid 35424072)
74. Ellies, L. G., Fishman, M., Hardison, J., Kleeman, J., Maglione, J. E., Manner, C. K., Cardiff, R. D., and, MacLeod, C. L., (2003) Mammary tumor latency is increased in mice lacking the inducible nitric oxide synthase. Int. J. Cancer 106, 1-7. (Pubitemid 36750381)
75. Rao, C. V., Indranie, C., Simi, B., Manning, P. T., Connor, J. R., and, Reddy, B. S., (2002) Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor. Cancer Res. 62, 165-170. (Pubitemid 34074001)
76. Thomsen, L. L., Scott, J. M., Topley, P., Knowles, R. G., Keerie, A. J., and, Frend, A. J., (1997) Selective inhibition of inducible nitric oxide synthase inhibits tumor growth in vivo: studies with 1400W, a novel inhibitor. Cancer Res. 57, 3300-3304. (Pubitemid 27351750)
77. Ohtsu, N., Takaoka, K., Segawa, E., Hashitani, S., Noguchi, K., Kishimoto, H., and, Urade, M., (2010) Antitumor effects of inhibitors of nitric oxide synthase or cyclooxygenase-2 on human KB carcinoma cells overexpressing COX-2. Oncol Rep. 24, 31-36.
78. Desai, D., Madhunapantula, S. V., Gowdahalli, K., Sharma, A., Chandagaludoreswamy, R., El-Bayoumy, K., Robertson, G. P., and, Amin, S., (2010) Synthesis and characterization of a novel iNOS/Akt inhibitor Se,Se'-1,4-phenylenebis(1,2-ethanediyl)bisisoselenourea (PBISe) - against colon cancer. Bioorg. Med. Chem. Lett. 20, 2038-2043.
79. Shen, J., Lee, W., Li, Y., Lau, C. F., Ng, K. M., Fung, M. L., and, Liu, K. J., (2008) Interaction of caveolin-1, nitric oxide, and nitric oxide synthases in hypoxic human SK-N-MC neuroblastoma cells. J. Neurochem. 107, 478-487.
80. Xie, K., Huang, S., Dong, Z., Juang, S. H., Gutman, M., Xie, Q. W., Nathan, C., and, Fidler, I. J., (1995) Transfection with the inducible nitric oxide synthase gene suppresses tumorigenicity and abrogates metastasis by K-1735 murine melanoma cells. J. Exp. Med. 181, 1333-1343.
81. Xu, W., Liu, L., and, Charles, I. G., (2002) Microencapsulated iNOS-expressing cells cause tumor suppression in mice. FASEB J. 16, 213-215.
82. Sikora, A. G., Gelbard, A., Davies, M. A., Sano, D., Ekmekcioglu, S., Kwon, J., Hailemichael, Y., Jayaraman, P., Myers, J. N., Grimm, E. A., and, Overwijk, W. W., (2010) Targeted inhibition of inducible nitric oxide synthase inhibits growth of human melanoma in vivo and synergizes with chemotherapy. Clin. Cancer Res. 16, 1834-1844.
83. Mosmann, T., (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol Methods 65, 55-63. (Pubitemid 14203433)
84. Ruiz-Stewart, I., Tiyyagura, S. R., Lin, J. E., Kazerounian, S., Pitari, G. M., Schulz, S., Martin, E., Murad, F., and, Waldman, S. A., (2004) Guanylyl cyclase is an ATP sensor coupling nitric oxide signaling to cell metabolism. Proc. Natl. Acad. Sci. USA 101, 37-42. (Pubitemid 38084199)
85. Konopka, T. E., Barker, J. E., Bamford, T. L., Guida, E., Anderson, R. L., and, Stewart, A. G., (2001) Nitric oxide synthase II gene disruption: implications for tumor growth and vascular endothelial growth factor production. Cancer Res. 61, 3182-3187. (Pubitemid 32691973)
86. Cullis, E. R., Kalber, T. L., Ashton, S. E., Cartwright, J. E., Griffiths, J. R., Ryan, A. J., and, Robinson, S. P., (2006) Tumour overexpression of inducible nitric oxide synthase (iNOS) increases angiogenesis and may modulate the anti-tumour effects of the vascular disrupting agent ZD6126. Microvasc. Res. 71, 76-84.
87. Gauthier, N., Lohm, S., Touzery, C., Chantome, A., Perette, B., Reveneau, S., Brunotte, F., Juillerat-Jeanneret, L., and, Jeannin, J. F., (2004) Tumour-derived and host-derived nitric oxide differentially regulate breast carcinoma metastasis to the lungs. Carcinogenesis 25, 1559-1565. (Pubitemid 39214297)
88. Deguchi, A., Thompson, W. J., and, Weinstein, I. B., (2004) Activation of protein kinase G is sufficient to induce apoptosis and inhibit cell migration in colon cancer cells. Cancer Res. 64, 3966-3973. (Pubitemid 38697311)
89. Leung, E. L., Wong, J. C., Johlfs, M. G., Tsang, B. K., and, Fiscus, R. R., (2010) Protein kinase G type Ialpha activity in human ovarian cancer cells significantly contributes to enhanced Src activation and DNA synthesis/cell proliferation. Mol. Cancer Res. 8, 578-591.
90. Swartling, F. J., Ferletta, M., Kastemar, M., Weiss, W. A., and, Westermark, B., (2009) Cyclic GMP-dependent protein kinase II inhibits cell proliferation, Sox9 expression and Akt phosphorylation in human glioma cell lines. Oncogene 28, 3121-3131.